A61K 51/1227
Micelles
Official title: {Micelles, e.g. phospholipidic or polymeric micelles}
A61K51/1227 (Micelles) appears on 25 US grants and 38 published applications in this corpus.
Search patents in A61K- Granted patents
- 25
- Published applications
- 38
- Assignees
- 38
- Inventors
- 121
- Latest grant
- 21 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 2 |
| 2003 | 0 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 0 | 0 |
| 2016 | 2 | 2 |
| 2017 | 3 | 3 |
| 2018 | 2 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 4 |
| 2021 | 2 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 2 |
| 2025 | 1 | 2 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic peptides21 Oct 2025US 12,448,425 B2Board of Regents, The University of Texas System
- Porphyrin modified telodendrimers11 Jan 2022US 11,219,692 B2The Regents of the University of California
- Gadolinium expressed lipid nanoparticles for magnetic resonance imaging28 Dec 2021US 11,207,430 B2University of Washington
- Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions26 Jan 2021US 10,898,436 B2Topas Therapeutics GmbH
- Bis-polymer lipid-peptide conjugates and nanoparticles thereof20 Oct 2020US 10,806,702 B2The Regents of the University of California
- Perfluorinated micelles and medical uses thereof16 Jul 2026US 2026/0199236 A1Centre National De La Recherche Scientifique
- Methods for inhibiting trained immunity with nanobiologic compositions3 Jul 2025US 2025/0213665 A1Icahn School of Medicine at Mount Sinai
- Composition and method for diagnostic imaging17 Apr 2025US 2025/0121100 A1Suntec Medical, Inc.
- Palm for the treatment of chemotherapy-induced peripheral neuropathy incidental to the treatment of cancer13 Jun 2024US 2024/0189230 A1Peptinovo Biopharma, LLC
- Hdl mimicking targeted drug delivery system for the treatment of solid tumors30 May 2024US 2024/0173256 A1University of North Texas Health Science Center
Most cited
By later US patents
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Targeted diagnostic/therapeutic agents having more than one different vectors95US 6,331,289 B1Nycomed Imaging AS · 2001
- Ultrasonic concentration of drug delivery capsules92US 7,358,226 B2The Regents of the University of California · 2008
- Lipid membrane drug delivery83US 4,377,567 AThe Procter & Gamble Company · 1983
- Vesicle stabilization83US 5,008,109 AVestar, Inc. · 1991